Ivonescimab Plus Chemotherapy Fails Cost-Effectiveness Test in Advanced Squamous Lung Cancer
A cost-effectiveness model based on the HARMONi-6 trial finds that ivonescimab plus chemotherapy is unlikely to be cost-effective for advanced ...
Tag: HARMONi-6 trial
POPULAR NEWS
-
Ivonescimab Plus Chemotherapy Fails Cost-Effectiveness Test in Advanced Squamous Lung Cancer
-
Cystic Fibrosis Macrophages Show Impaired Defense Against Resistant Lung Pathogen
-
Hot Springs of Qingyuan Trace Their Origins to Rain and Deep Faults
-
Leaf-Canopy Decoupling: Why Healthy Leaves Can Still Mean Hungry Crops Under Nitrogen Stress